$414 Million is the total value of Endurant Capital Management LP's 68 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 103.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | INVACARE CORPnote 5.000%11/1 | $51,054,000 | – | 56,727,000 | +100.0% | 12.32% | – | |
| SPY | Buy | SPDR S&P 500 ETF TRput | $28,990,000 | -60.7% | 60,900 | +140.7% | 7.00% | -58.4% |
| SNY | Buy | SANOFIsponsored adr | $21,267,000 | +704.7% | 424,490 | +674.3% | 5.13% | +752.7% |
| LH | Buy | LABORATORY CORP AMER HLDGS | $20,541,000 | +287.6% | 65,372 | +247.2% | 4.96% | +310.8% |
| AZN | New | ASTRAZENECA PLCsponsored adr | $18,915,000 | – | 324,728 | +100.0% | 4.57% | – |
| SIBN | Buy | SI-BONE INC | $17,038,000 | +68.8% | 767,126 | +62.8% | 4.11% | +78.9% |
| HUM | Sell | HUMANA INC | $15,762,000 | -8.0% | 33,981 | -22.8% | 3.80% | -2.5% |
| ABC | Buy | AMERISOURCEBERGEN CORP | $15,283,000 | +497.0% | 115,003 | +436.6% | 3.69% | +532.8% |
| HOLX | Sell | HOLOGIC INC | $13,863,000 | -6.1% | 181,068 | -9.5% | 3.35% | -0.5% |
| XBI | New | SPDR SER TRcall | $12,797,000 | – | 114,300 | +100.0% | 3.09% | – |
| THC | Sell | TENET HEALTHCARE CORP | $12,003,000 | +0.8% | 146,929 | -18.0% | 2.90% | +6.8% |
| BIO | Sell | BIO RAD LABS INCcl a | $10,985,000 | -19.4% | 14,539 | -20.4% | 2.65% | -14.6% |
| XRAY | Buy | DENTSPLY SIRONA INC | $9,617,000 | +173.3% | 172,384 | +184.4% | 2.32% | +189.8% |
| New | INVACARE CORPnote 5.000%11/1 | $9,567,000 | – | 10,097,000 | +100.0% | 2.31% | – | |
| BDX | Buy | BECTON DICKINSON & CO | $8,664,000 | +218.2% | 34,452 | +211.0% | 2.09% | +237.3% |
| CI | Buy | CIGNA CORP NEW | $8,415,000 | +16.2% | 36,646 | +1.3% | 2.03% | +23.2% |
| SYNH | Sell | SYNEOS HEALTH INCcl a | $7,729,000 | -4.8% | 75,275 | -18.9% | 1.87% | +1.0% |
| JNJ | Sell | JOHNSON & JOHNSON | $7,315,000 | -53.8% | 42,762 | -56.4% | 1.77% | -51.0% |
| CRL | New | CHARLES RIV LABS INTL INC | $7,003,000 | – | 18,586 | +100.0% | 1.69% | – |
| SELB | Buy | SELECTA BIOSCIENCES INC | $6,923,000 | +62.9% | 2,123,526 | +107.9% | 1.67% | +72.6% |
| AZYO | Buy | AZIYO BIOLOGICS INC | $6,777,000 | +2.3% | 1,075,640 | +12.9% | 1.64% | +8.4% |
| PKI | Buy | PERKINELMER INC | $5,940,000 | +78.0% | 29,543 | +53.4% | 1.43% | +88.7% |
| CNC | New | CENTENE CORP DEL | $5,835,000 | – | 70,809 | +100.0% | 1.41% | – |
| XBI | New | SPDR SER TRs&p biotech | $5,476,000 | – | 48,906 | +100.0% | 1.32% | – |
| OCDX | New | ORTHO CLINICAL DIAGNOSTICS H | $5,251,000 | – | 245,484 | +100.0% | 1.27% | – |
| RCM | Sell | R1 RCM INC | $5,236,000 | -15.9% | 205,400 | -27.4% | 1.26% | -10.9% |
| OCUL | Buy | OCULAR THERAPEUTIX INC | $4,998,000 | -18.1% | 717,143 | +17.5% | 1.21% | -13.2% |
| AVTR | Sell | AVANTOR INC | $4,509,000 | -31.9% | 106,996 | -33.9% | 1.09% | -27.9% |
| HAE | New | HAEMONETICS CORP MASS | $3,920,000 | – | 73,914 | +100.0% | 0.95% | – |
| VCYT | Sell | VERACYTE INC | $3,599,000 | -53.9% | 87,343 | -48.1% | 0.87% | -51.2% |
| ADAP | Sell | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $3,366,000 | -29.0% | 897,579 | -2.2% | 0.81% | -24.8% |
| SRPT | New | SAREPTA THERAPEUTICS INC | $2,989,000 | – | 33,191 | +100.0% | 0.72% | – |
| KNSA | New | KINIKSA PHARMACEUTICALS LTD | $2,873,000 | – | 244,125 | +100.0% | 0.69% | – |
| IWM | New | ISHARES TRput | $2,669,000 | – | 12,000 | +100.0% | 0.64% | – |
| ZGNX | New | ZOGENIX INC | $2,610,000 | – | 160,640 | +100.0% | 0.63% | – |
| INSM | Sell | INSMED INC | $2,430,000 | -44.8% | 89,211 | -44.2% | 0.59% | -41.5% |
| AHCO | Sell | ADAPTHEALTH CORP | $2,395,000 | -47.2% | 97,926 | -49.8% | 0.58% | -44.1% |
| GDRX | New | GOODRX HLDGS INC | $2,242,000 | – | 68,599 | +100.0% | 0.54% | – |
| FATE | New | FATE THERAPEUTICS INC | $2,184,000 | – | 37,325 | +100.0% | 0.53% | – |
| AXSM | Buy | AXSOME THERAPEUTICS INC | $2,102,000 | +22.5% | 55,629 | +6.9% | 0.51% | +29.7% |
| RYTM | New | RHYTHM PHARMACEUTICALS INC | $1,971,000 | – | 197,462 | +100.0% | 0.48% | – |
| ICUI | New | ICU MED INC | $1,843,000 | – | 7,766 | +100.0% | 0.44% | – |
| PRAX | Sell | PRAXIS PRECISION MEDICINES I | $1,764,000 | -37.9% | 89,561 | -41.7% | 0.43% | -34.2% |
| IMUX | Sell | IMMUNIC INC | $1,766,000 | +7.6% | 184,543 | -0.5% | 0.43% | +13.9% |
| PODD | New | INSULET CORP | $1,701,000 | – | 6,394 | +100.0% | 0.41% | – |
| ATRC | New | ATRICURE INC | $1,686,000 | – | 24,253 | +100.0% | 0.41% | – |
| STRO | New | SUTRO BIOPHARMA INC | $1,664,000 | – | 111,803 | +100.0% | 0.40% | – |
| AUPH | New | AURINIA PHARMACEUTICALS INC | $1,531,000 | – | 66,935 | +100.0% | 0.37% | – |
| ALBO | Sell | ALBIREO PHARMA INC | $1,529,000 | -58.2% | 65,638 | -44.1% | 0.37% | -55.8% |
| HRTX | New | HERON THERAPEUTICS INC | $1,510,000 | – | 165,404 | +100.0% | 0.36% | – |
| VRDN | New | VIRIDIAN THERAPEUTICS INC | $1,333,000 | – | 67,450 | +100.0% | 0.32% | – |
| GOSS | New | GOSSAMER BIO INC | $1,285,000 | – | 113,660 | +100.0% | 0.31% | – |
| NRIX | New | NURIX THERAPEUTICS INC | $1,261,000 | – | 43,542 | +100.0% | 0.30% | – |
| GBT | New | GLOBAL BLOOD THERAPEUTICS IN | $1,253,000 | – | 42,797 | +100.0% | 0.30% | – |
| Sell | DARIOHEALTH CORP | $1,180,000 | -42.4% | 90,975 | -39.4% | 0.28% | -38.8% | |
| ARAY | New | ACCURAY INC | $1,172,000 | – | 245,764 | +100.0% | 0.28% | – |
| TMCI | New | TREACE MED CONCEPTS INC | $1,066,000 | – | 57,175 | +100.0% | 0.26% | – |
| MTEM | Sell | MOLECULAR TEMPLATES INC | $1,052,000 | -74.4% | 268,375 | -56.3% | 0.25% | -72.9% |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $1,031,000 | -68.1% | 53,981 | -58.8% | 0.25% | -66.2% |
| OMI | Sell | OWENS & MINOR INC NEW | $978,000 | -84.7% | 22,489 | -89.0% | 0.24% | -83.7% |
| PHAS | Sell | PHASEBIO PHARMACEUTICALS INC | $940,000 | -73.3% | 360,078 | -68.2% | 0.23% | -71.7% |
| BHVN | New | BIOHAVEN PHARMACTL HLDG CO L | $836,000 | – | 6,069 | +100.0% | 0.20% | – |
| CYH | New | COMMUNITY HEALTH SYS INC NEW | $597,000 | – | 44,847 | +100.0% | 0.14% | – |
| OFIX | New | ORTHOFIX MED INC | $585,000 | – | 18,817 | +100.0% | 0.14% | – |
| HGEN | New | HUMANIGEN INC | $575,000 | – | 154,613 | +100.0% | 0.14% | – |
| SBTX | New | SILVERBACK THERAPEUTICS INC | $561,000 | – | 84,295 | +100.0% | 0.14% | – |
| ANGO | New | ANGIODYNAMICS INC | $500,000 | – | 18,125 | +100.0% | 0.12% | – |
| ATNM | New | ACTINIUM PHARMACEUTICALS INC | $0 | – | 66,666 | +100.0% | 0.00% | – |
| IVC | Exit | INVACARE CORP | $0 | – | -1,146,068 | -100.0% | -0.07% | – |
| CYAD | Exit | CELYAD ONCOLOGY SAadr | $0 | – | -145,380 | -100.0% | -0.14% | – |
| PDCO | Exit | PATTERSON COS INC | $0 | – | -26,799 | -100.0% | -0.18% | – |
| XENE | Exit | XENON PHARMACEUTICALS INC | $0 | – | -62,743 | -100.0% | -0.22% | – |
| ALVR | Exit | ALLOVIR INC | $0 | – | -44,430 | -100.0% | -0.25% | – |
| BOLT | Exit | BOLT BIOTHERAPEUTICS INC | $0 | – | -90,041 | -100.0% | -0.26% | – |
| KRYS | Exit | KRYSTAL BIOTECH INC | $0 | – | -22,938 | -100.0% | -0.27% | – |
| ACRS | Exit | ACLARIS THERAPEUTICS INC | $0 | – | -67,300 | -100.0% | -0.28% | – |
| MRVI | Exit | MARAVAI LIFESCIENCES HLDGS I | $0 | – | -29,838 | -100.0% | -0.33% | – |
| MREO | Exit | MEREO BIOPHARMA GROUP PLCads | $0 | – | -746,514 | -100.0% | -0.41% | – |
| BLU | Exit | BELLUS HEALTH INC NEW | $0 | – | -389,833 | -100.0% | -0.54% | – |
| RGLS | Exit | REGULUS THERAPEUTICS INC | $0 | – | -3,547,208 | -100.0% | -0.56% | – |
| ATR | Exit | APTARGROUP INC | $0 | – | -51,191 | -100.0% | -1.39% | – |
| Exit | INVACARE CORPnote 5.000%11/1 | $0 | – | -7,000,000 | -100.0% | -1.41% | – | |
| MCK | Exit | MCKESSON CORP | $0 | – | -32,551 | -100.0% | -1.48% | – |
| ICLR | Exit | ICON PLC | $0 | – | -46,720 | -100.0% | -2.79% | – |
| BMY | Exit | BRISTOL-MYERS SQUIBB CO | $0 | – | -211,821 | -100.0% | -2.85% | – |
| ABBV | Exit | ABBVIE INC | $0 | – | -180,429 | -100.0% | -4.43% | – |
| Exit | TRILLIUM THERAPEUTICS INCcall | $0 | – | -206,800 | -100.0% | -8.27% | – | |
| Exit | INVACARE CORPnote 5.000%11/1 | $0 | – | -56,727,000 | -100.0% | -11.66% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LABORATORY CORP AMER HLDGS | 31 | Q2 2023 | 8.7% |
| ELEVANCE HEALTH INC | 29 | Q3 2023 | 8.8% |
| BECTON DICKINSON & CO | 28 | Q2 2023 | 9.8% |
| MCKESSON CORP | 27 | Q1 2023 | 4.4% |
| CENCORA INC | 26 | Q3 2023 | 5.9% |
| HOLOGIC INC | 24 | Q3 2023 | 7.5% |
| JOHNSON & JOHNSON | 24 | Q4 2021 | 5.5% |
| ZIMMER HLDGS INC | 23 | Q3 2023 | 7.5% |
| BOSTON SCIENTIFIC CORP | 22 | Q3 2023 | 5.5% |
| DAVITA INC | 22 | Q1 2021 | 4.9% |
View Endurant Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AZIYO BIOLOGICS, INC. | March 21, 2023 | 576,253 | 4.9% |
| Oxford Immunotec Global PLCSold out | February 17, 2021 | 0 | 0.0% |
View Endurant Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-10 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13D/A | 2023-09-08 |
| 13F-HR | 2023-08-14 |
| 3/A | 2023-05-24 |
| 13F-HR | 2023-05-15 |
| 3 | 2023-05-15 |
| SC 13D | 2023-05-15 |
| SC 13G/A | 2023-03-21 |
View Endurant Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.